Lalit Bajaj
Concepts (327)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchiolitis | 8 | 2022 | 80 | 3.660 |
Why?
| | Emergency Service, Hospital | 56 | 2025 | 2069 | 3.160 |
Why?
| | Sepsis | 10 | 2023 | 617 | 2.110 |
Why?
| | Lactic Acid | 3 | 2017 | 305 | 1.390 |
Why?
| | Bacterial Infections | 2 | 2022 | 250 | 1.260 |
Why?
| | Appendicitis | 11 | 2022 | 130 | 1.240 |
Why?
| | Oxygen Inhalation Therapy | 4 | 2022 | 157 | 1.200 |
Why?
| | Hospitals, Pediatric | 12 | 2023 | 508 | 1.160 |
Why?
| | Analgesics, Opioid | 6 | 2022 | 1000 | 1.150 |
Why?
| | Child | 74 | 2025 | 21935 | 1.110 |
Why?
| | Epilepsy | 2 | 2020 | 333 | 0.960 |
Why?
| | Fractures, Bone | 5 | 2021 | 380 | 0.900 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 3 | 2022 | 234 | 0.900 |
Why?
| | Emergencies | 4 | 2015 | 164 | 0.850 |
Why?
| | Endocrine System Diseases | 3 | 2015 | 35 | 0.850 |
Why?
| | Pediatric Emergency Medicine | 2 | 2024 | 24 | 0.810 |
Why?
| | Emergency Medical Services | 6 | 2019 | 552 | 0.790 |
Why?
| | Infant | 31 | 2025 | 9465 | 0.760 |
Why?
| | Medical Overuse | 3 | 2024 | 30 | 0.740 |
Why?
| | Soft Tissue Infections | 1 | 2022 | 37 | 0.740 |
Why?
| | Chorioamnionitis | 1 | 2022 | 42 | 0.740 |
Why?
| | Decision Support Systems, Clinical | 6 | 2025 | 226 | 0.740 |
Why?
| | Ketamine | 5 | 2017 | 94 | 0.740 |
Why?
| | Mastitis | 1 | 2021 | 5 | 0.730 |
Why?
| | Acute Pain | 2 | 2021 | 50 | 0.730 |
Why?
| | Craniocerebral Trauma | 3 | 2019 | 170 | 0.730 |
Why?
| | Gastroenteritis | 1 | 2022 | 69 | 0.710 |
Why?
| | Home Care Services | 2 | 2022 | 257 | 0.690 |
Why?
| | Infant, Newborn, Diseases | 1 | 2022 | 113 | 0.680 |
Why?
| | Staphylococcal Infections | 2 | 2022 | 400 | 0.670 |
Why?
| | Skin Diseases | 1 | 2022 | 149 | 0.670 |
Why?
| | Underage Drinking | 4 | 2021 | 22 | 0.640 |
Why?
| | Shock, Septic | 4 | 2025 | 219 | 0.640 |
Why?
| | Metabolic Diseases | 2 | 2015 | 108 | 0.610 |
Why?
| | Humans | 91 | 2025 | 137585 | 0.600 |
Why?
| | Retrospective Studies | 29 | 2023 | 15657 | 0.600 |
Why?
| | Plant Extracts | 1 | 2020 | 202 | 0.580 |
Why?
| | Child, Preschool | 36 | 2025 | 11074 | 0.580 |
Why?
| | Cannabidiol | 1 | 2020 | 119 | 0.580 |
Why?
| | Anticonvulsants | 1 | 2020 | 217 | 0.580 |
Why?
| | Quality Improvement | 7 | 2024 | 1178 | 0.570 |
Why?
| | Adolescent | 46 | 2025 | 21513 | 0.570 |
Why?
| | Practice Patterns, Physicians' | 7 | 2022 | 1313 | 0.560 |
Why?
| | Hospitalization | 8 | 2022 | 2199 | 0.550 |
Why?
| | Patient Admission | 2 | 2019 | 197 | 0.540 |
Why?
| | Medical Marijuana | 1 | 2019 | 117 | 0.540 |
Why?
| | Anti-Bacterial Agents | 6 | 2025 | 1809 | 0.510 |
Why?
| | Dronabinol | 1 | 2019 | 226 | 0.510 |
Why?
| | Multiple Organ Failure | 2 | 2022 | 128 | 0.510 |
Why?
| | Hospital Mortality | 3 | 2022 | 911 | 0.500 |
Why?
| | Capnography | 1 | 2015 | 16 | 0.490 |
Why?
| | Oximetry | 1 | 2016 | 96 | 0.480 |
Why?
| | Infant, Newborn | 13 | 2022 | 6079 | 0.470 |
Why?
| | Pediatrics | 7 | 2019 | 1101 | 0.470 |
Why?
| | Health Care Costs | 1 | 2018 | 398 | 0.470 |
Why?
| | Airway Management | 1 | 2015 | 52 | 0.470 |
Why?
| | Fever | 2 | 2022 | 306 | 0.450 |
Why?
| | Male | 55 | 2025 | 67762 | 0.440 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 93 | 0.440 |
Why?
| | Patient Readmission | 3 | 2018 | 697 | 0.440 |
Why?
| | Clinical Laboratory Techniques | 2 | 2018 | 97 | 0.430 |
Why?
| | Female | 54 | 2025 | 73304 | 0.420 |
Why?
| | Prospective Studies | 21 | 2025 | 7604 | 0.420 |
Why?
| | Anesthetics, Dissociative | 3 | 2017 | 30 | 0.420 |
Why?
| | Asthma | 3 | 2022 | 2295 | 0.390 |
Why?
| | Patient Discharge | 4 | 2020 | 897 | 0.390 |
Why?
| | Triage | 1 | 2015 | 222 | 0.390 |
Why?
| | Intensive Care Units | 2 | 2015 | 827 | 0.380 |
Why?
| | Patient Transfer | 1 | 2015 | 176 | 0.380 |
Why?
| | Tertiary Healthcare | 2 | 2021 | 33 | 0.370 |
Why?
| | Ambulatory Care | 3 | 2021 | 546 | 0.370 |
Why?
| | Emergency Treatment | 4 | 2020 | 118 | 0.360 |
Why?
| | Caregivers | 3 | 2017 | 877 | 0.360 |
Why?
| | Delivery of Health Care | 1 | 2018 | 951 | 0.360 |
Why?
| | Disease Management | 1 | 2015 | 628 | 0.350 |
Why?
| | Abdominal Pain | 6 | 2016 | 145 | 0.340 |
Why?
| | Guideline Adherence | 4 | 2020 | 556 | 0.330 |
Why?
| | Sensitivity and Specificity | 9 | 2019 | 1946 | 0.330 |
Why?
| | Conscious Sedation | 4 | 2017 | 92 | 0.320 |
Why?
| | Drug Prescriptions | 3 | 2022 | 245 | 0.320 |
Why?
| | Diagnostic Errors | 3 | 2022 | 170 | 0.320 |
Why?
| | Practice Guidelines as Topic | 5 | 2018 | 1587 | 0.310 |
Why?
| | United States | 15 | 2024 | 14841 | 0.310 |
Why?
| | Risk Assessment | 6 | 2019 | 3457 | 0.300 |
Why?
| | Vomiting | 3 | 2008 | 130 | 0.300 |
Why?
| | Cohort Studies | 10 | 2020 | 5742 | 0.290 |
Why?
| | Ondansetron | 1 | 2008 | 16 | 0.290 |
Why?
| | Cannabis | 3 | 2021 | 494 | 0.290 |
Why?
| | Quality of Health Care | 3 | 2023 | 642 | 0.280 |
Why?
| | Head Injuries, Closed | 2 | 2018 | 48 | 0.280 |
Why?
| | Antiemetics | 1 | 2008 | 43 | 0.280 |
Why?
| | Pain Management | 2 | 2020 | 352 | 0.260 |
Why?
| | Canada | 4 | 2024 | 418 | 0.260 |
Why?
| | Appendectomy | 5 | 2022 | 79 | 0.260 |
Why?
| | Time Factors | 11 | 2020 | 6828 | 0.250 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2006 | 10 | 0.250 |
Why?
| | Cross-Sectional Studies | 12 | 2021 | 5472 | 0.250 |
Why?
| | Magnesium | 2 | 2020 | 156 | 0.240 |
Why?
| | Hypnotics and Sedatives | 2 | 2006 | 200 | 0.230 |
Why?
| | Registries | 5 | 2020 | 2035 | 0.220 |
Why?
| | Electronic Health Records | 5 | 2023 | 1069 | 0.220 |
Why?
| | Spain | 2 | 2021 | 41 | 0.220 |
Why?
| | Intussusception | 1 | 2003 | 28 | 0.210 |
Why?
| | Orthopedic Procedures | 1 | 2006 | 216 | 0.210 |
Why?
| | Enema | 1 | 2003 | 47 | 0.210 |
Why?
| | Unnecessary Procedures | 1 | 2024 | 50 | 0.210 |
Why?
| | Anaphylaxis | 1 | 2005 | 105 | 0.210 |
Why?
| | Alcoholism | 2 | 2021 | 807 | 0.200 |
Why?
| | Critical Care | 2 | 2021 | 601 | 0.200 |
Why?
| | Intubation, Intratracheal | 2 | 2015 | 257 | 0.200 |
Why?
| | Acute Disease | 7 | 2020 | 1007 | 0.200 |
Why?
| | Metabolism, Inborn Errors | 1 | 2003 | 41 | 0.200 |
Why?
| | Brain Injuries, Traumatic | 2 | 2018 | 360 | 0.200 |
Why?
| | Tomography, X-Ray Computed | 6 | 2018 | 2691 | 0.190 |
Why?
| | Physical Examination | 2 | 2015 | 241 | 0.190 |
Why?
| | Prescription Drug Monitoring Programs | 1 | 2022 | 14 | 0.190 |
Why?
| | Drug Utilization | 3 | 2020 | 169 | 0.190 |
Why?
| | Communication Barriers | 2 | 2014 | 104 | 0.190 |
Why?
| | Prevalence | 2 | 2021 | 2734 | 0.180 |
Why?
| | Musculoskeletal Pain | 1 | 2021 | 37 | 0.180 |
Why?
| | Parental Consent | 1 | 2021 | 25 | 0.180 |
Why?
| | Length of Stay | 3 | 2022 | 1215 | 0.180 |
Why?
| | Substance-Related Disorders | 2 | 2021 | 1083 | 0.170 |
Why?
| | Follow-Up Studies | 5 | 2021 | 5131 | 0.170 |
Why?
| | Mass Screening | 2 | 2019 | 1287 | 0.170 |
Why?
| | Antimicrobial Stewardship | 1 | 2023 | 118 | 0.170 |
Why?
| | Community-Acquired Infections | 1 | 2023 | 174 | 0.170 |
Why?
| | Organ Dysfunction Scores | 2 | 2022 | 48 | 0.170 |
Why?
| | Treatment Outcome | 8 | 2020 | 10811 | 0.170 |
Why?
| | Diagnostic Imaging | 2 | 2014 | 332 | 0.160 |
Why?
| | Drug Hypersensitivity | 1 | 2021 | 90 | 0.160 |
Why?
| | Waiting Lists | 1 | 2022 | 266 | 0.160 |
Why?
| | Heuristics | 1 | 2019 | 9 | 0.160 |
Why?
| | Tracheostomy | 2 | 2015 | 133 | 0.160 |
Why?
| | Metabolic Clearance Rate | 1 | 2019 | 115 | 0.150 |
Why?
| | Half-Life | 1 | 2019 | 164 | 0.150 |
Why?
| | Advisory Committees | 1 | 2020 | 219 | 0.150 |
Why?
| | Biological Availability | 1 | 2019 | 148 | 0.150 |
Why?
| | Time-to-Treatment | 2 | 2025 | 205 | 0.150 |
Why?
| | First Aid | 1 | 2018 | 12 | 0.150 |
Why?
| | Machine Learning | 2 | 2025 | 493 | 0.150 |
Why?
| | Tissue Distribution | 1 | 2019 | 332 | 0.150 |
Why?
| | Marijuana Abuse | 1 | 2021 | 233 | 0.150 |
Why?
| | Severity of Illness Index | 4 | 2015 | 2828 | 0.140 |
Why?
| | Hospitals | 2 | 2021 | 691 | 0.140 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2021 | 257 | 0.140 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2018 | 103 | 0.140 |
Why?
| | Global Health | 2 | 2015 | 386 | 0.140 |
Why?
| | Community Health Centers | 1 | 2018 | 60 | 0.140 |
Why?
| | Healthcare Disparities | 3 | 2020 | 654 | 0.140 |
Why?
| | Inpatients | 1 | 2022 | 500 | 0.140 |
Why?
| | Oxygen | 1 | 2022 | 931 | 0.140 |
Why?
| | Incidence | 5 | 2019 | 2804 | 0.140 |
Why?
| | Motivation | 1 | 2022 | 570 | 0.140 |
Why?
| | Veins | 1 | 2017 | 63 | 0.130 |
Why?
| | Radiography, Thoracic | 1 | 2018 | 167 | 0.130 |
Why?
| | Intestinal Perforation | 1 | 2017 | 46 | 0.130 |
Why?
| | Staphylococcus aureus | 1 | 2021 | 450 | 0.130 |
Why?
| | Tertiary Care Centers | 1 | 2018 | 160 | 0.130 |
Why?
| | Inappropriate Prescribing | 1 | 2017 | 55 | 0.130 |
Why?
| | Surveys and Questionnaires | 5 | 2024 | 5778 | 0.130 |
Why?
| | Administration, Oral | 1 | 2019 | 816 | 0.130 |
Why?
| | Anemia, Sickle Cell | 1 | 2020 | 270 | 0.130 |
Why?
| | Prognosis | 4 | 2022 | 4030 | 0.130 |
Why?
| | Algorithms | 2 | 2019 | 1704 | 0.130 |
Why?
| | Propofol | 1 | 2017 | 73 | 0.130 |
Why?
| | Bronchodilator Agents | 1 | 2018 | 252 | 0.130 |
Why?
| | Anesthetics, Intravenous | 2 | 2015 | 47 | 0.130 |
Why?
| | Ultrasonography | 2 | 2018 | 759 | 0.130 |
Why?
| | Comorbidity | 1 | 2021 | 1622 | 0.130 |
Why?
| | Faculty, Medical | 1 | 2019 | 283 | 0.120 |
Why?
| | Ultrasonography, Doppler | 2 | 2014 | 124 | 0.120 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 232 | 0.120 |
Why?
| | Decision Support Techniques | 3 | 2017 | 421 | 0.120 |
Why?
| | Laryngeal Masks | 1 | 2015 | 14 | 0.120 |
Why?
| | Informed Consent | 1 | 2017 | 175 | 0.120 |
Why?
| | Colorado | 7 | 2020 | 4565 | 0.120 |
Why?
| | Arteries | 1 | 2017 | 269 | 0.120 |
Why?
| | Marijuana Smoking | 1 | 2019 | 252 | 0.120 |
Why?
| | Larynx | 1 | 2015 | 60 | 0.120 |
Why?
| | Data Collection | 1 | 2018 | 673 | 0.120 |
Why?
| | Virus Diseases | 1 | 2017 | 212 | 0.120 |
Why?
| | Spinal Fractures | 1 | 2015 | 73 | 0.120 |
Why?
| | Confidence Intervals | 2 | 2013 | 329 | 0.110 |
Why?
| | Hypotension | 1 | 2015 | 122 | 0.110 |
Why?
| | Morbidity | 1 | 2015 | 324 | 0.110 |
Why?
| | Elective Surgical Procedures | 1 | 2015 | 179 | 0.110 |
Why?
| | Body Temperature | 1 | 2015 | 222 | 0.110 |
Why?
| | Analgesia | 2 | 2005 | 94 | 0.110 |
Why?
| | Burns | 1 | 2018 | 325 | 0.110 |
Why?
| | International Classification of Diseases | 1 | 2015 | 135 | 0.110 |
Why?
| | Trachea | 1 | 2015 | 237 | 0.110 |
Why?
| | Blood Cell Count | 2 | 2013 | 55 | 0.100 |
Why?
| | Patient Care Team | 1 | 2018 | 631 | 0.100 |
Why?
| | Etomidate | 1 | 2012 | 7 | 0.100 |
Why?
| | Patient Compliance | 1 | 2017 | 581 | 0.100 |
Why?
| | Patient Selection | 1 | 2017 | 696 | 0.100 |
Why?
| | Telephone | 2 | 2012 | 173 | 0.100 |
Why?
| | Cerebral Arterial Diseases | 1 | 2012 | 47 | 0.100 |
Why?
| | Asymptomatic Diseases | 1 | 2013 | 89 | 0.100 |
Why?
| | Wounds, Nonpenetrating | 1 | 2015 | 278 | 0.100 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2012 | 82 | 0.100 |
Why?
| | Translating | 1 | 2012 | 43 | 0.090 |
Why?
| | Age Factors | 2 | 2016 | 3295 | 0.090 |
Why?
| | Poisoning | 1 | 2013 | 120 | 0.090 |
Why?
| | Alcohol Drinking | 1 | 2019 | 828 | 0.090 |
Why?
| | ROC Curve | 3 | 2022 | 554 | 0.090 |
Why?
| | Cost Savings | 1 | 2012 | 84 | 0.090 |
Why?
| | Emergency Medicine | 2 | 2024 | 226 | 0.090 |
Why?
| | Brain Concussion | 2 | 2016 | 574 | 0.090 |
Why?
| | Post-Concussion Syndrome | 1 | 2014 | 175 | 0.090 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 431 | 0.090 |
Why?
| | Heart Rate | 1 | 2015 | 822 | 0.090 |
Why?
| | Blood Coagulation Disorders | 1 | 2012 | 173 | 0.090 |
Why?
| | Language | 2 | 2012 | 292 | 0.090 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2019 | 1329 | 0.090 |
Why?
| | Risk | 2 | 2012 | 912 | 0.080 |
Why?
| | Intraocular Pressure | 1 | 2012 | 307 | 0.080 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 270 | 0.080 |
Why?
| | Electrocardiography | 1 | 2013 | 629 | 0.080 |
Why?
| | Reproducibility of Results | 5 | 2019 | 3284 | 0.080 |
Why?
| | Infusions, Intravenous | 2 | 2010 | 413 | 0.080 |
Why?
| | Spinal Puncture | 1 | 2009 | 17 | 0.080 |
Why?
| | Communication | 2 | 2019 | 879 | 0.080 |
Why?
| | Continuity of Patient Care | 1 | 2012 | 284 | 0.080 |
Why?
| | Pregnancy | 1 | 2022 | 6763 | 0.080 |
Why?
| | Diagnosis, Differential | 3 | 2012 | 1483 | 0.080 |
Why?
| | Logistic Models | 4 | 2017 | 2074 | 0.080 |
Why?
| | Bacteriological Techniques | 1 | 2009 | 73 | 0.080 |
Why?
| | Academic Medical Centers | 1 | 2012 | 512 | 0.080 |
Why?
| | Critical Illness | 1 | 2015 | 811 | 0.070 |
Why?
| | Glasgow Coma Scale | 2 | 2017 | 186 | 0.070 |
Why?
| | Drug Overdose | 1 | 2013 | 347 | 0.070 |
Why?
| | Age Distribution | 1 | 2009 | 392 | 0.070 |
Why?
| | Adult | 8 | 2022 | 37929 | 0.070 |
Why?
| | Urinalysis | 2 | 2013 | 77 | 0.070 |
Why?
| | Biomarkers | 2 | 2016 | 4149 | 0.070 |
Why?
| | Venous Thromboembolism | 1 | 2011 | 316 | 0.070 |
Why?
| | Mental Disorders | 1 | 2016 | 1077 | 0.070 |
Why?
| | United Kingdom | 2 | 2018 | 318 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 530 | 0.070 |
Why?
| | Anesthesia Recovery Period | 1 | 2006 | 16 | 0.070 |
Why?
| | Community Medicine | 1 | 2006 | 6 | 0.060 |
Why?
| | Fentanyl | 3 | 2015 | 94 | 0.060 |
Why?
| | Anti-Asthmatic Agents | 1 | 2010 | 395 | 0.060 |
Why?
| | Injections, Intramuscular | 1 | 2006 | 129 | 0.060 |
Why?
| | Recurrence | 2 | 2012 | 1060 | 0.060 |
Why?
| | Adrenergic Agonists | 1 | 2005 | 5 | 0.060 |
Why?
| | Potassium | 1 | 2005 | 147 | 0.060 |
Why?
| | Histamine H1 Antagonists | 1 | 2005 | 30 | 0.060 |
Why?
| | Hemolysis | 1 | 2005 | 206 | 0.050 |
Why?
| | Stroke | 1 | 2012 | 1120 | 0.050 |
Why?
| | Attitude | 1 | 2006 | 259 | 0.050 |
Why?
| | Fluid Therapy | 1 | 2005 | 147 | 0.050 |
Why?
| | Hemoglobins | 1 | 2005 | 353 | 0.050 |
Why?
| | Double-Blind Method | 1 | 2008 | 1993 | 0.050 |
Why?
| | Radiography | 2 | 2015 | 822 | 0.050 |
Why?
| | Fasting | 1 | 2004 | 281 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 2031 | 0.050 |
Why?
| | Blood Specimen Collection | 1 | 2002 | 41 | 0.050 |
Why?
| | Midazolam | 2 | 2015 | 56 | 0.040 |
Why?
| | Penicillins | 1 | 2021 | 58 | 0.040 |
Why?
| | Neutrophils | 2 | 2016 | 1238 | 0.040 |
Why?
| | Prescriptions | 1 | 2020 | 67 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2005 | 594 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2020 | 91 | 0.040 |
Why?
| | National Institute on Alcohol Abuse and Alcoholism (U.S.) | 1 | 2019 | 1 | 0.040 |
Why?
| | Survival Rate | 1 | 2005 | 1972 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2022 | 3556 | 0.040 |
Why?
| | Critical Pathways | 1 | 2020 | 96 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2020 | 155 | 0.040 |
Why?
| | Drug Therapy, Combination | 2 | 2017 | 1066 | 0.040 |
Why?
| | Non-Randomized Controlled Trials as Topic | 1 | 2018 | 20 | 0.040 |
Why?
| | Consensus | 1 | 2022 | 683 | 0.040 |
Why?
| | Wales | 1 | 2018 | 23 | 0.040 |
Why?
| | Reference Values | 2 | 2014 | 816 | 0.040 |
Why?
| | Information Dissemination | 1 | 2020 | 218 | 0.040 |
Why?
| | Abdomen, Acute | 1 | 2018 | 21 | 0.040 |
Why?
| | Needs Assessment | 1 | 2020 | 376 | 0.040 |
Why?
| | Portugal | 1 | 2017 | 10 | 0.040 |
Why?
| | Outpatients | 1 | 2021 | 396 | 0.040 |
Why?
| | Ireland | 1 | 2017 | 30 | 0.040 |
Why?
| | Interprofessional Relations | 1 | 2020 | 283 | 0.040 |
Why?
| | Quality Control | 1 | 2018 | 172 | 0.040 |
Why?
| | Research | 1 | 2021 | 451 | 0.040 |
Why?
| | New Zealand | 1 | 2017 | 56 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2018 | 213 | 0.030 |
Why?
| | Australia | 1 | 2017 | 315 | 0.030 |
Why?
| | Lymphocyte Count | 1 | 2016 | 148 | 0.030 |
Why?
| | Emotional Adjustment | 1 | 2016 | 17 | 0.030 |
Why?
| | Risk Factors | 3 | 2019 | 10388 | 0.030 |
Why?
| | Program Evaluation | 1 | 2020 | 898 | 0.030 |
Why?
| | Area Under Curve | 1 | 2016 | 314 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2016 | 329 | 0.030 |
Why?
| | Neuromuscular Nondepolarizing Agents | 1 | 2015 | 17 | 0.030 |
Why?
| | Androstanols | 1 | 2015 | 18 | 0.030 |
Why?
| | Medical Order Entry Systems | 1 | 2015 | 43 | 0.030 |
Why?
| | Laryngoscopy | 1 | 2015 | 109 | 0.030 |
Why?
| | Pilot Projects | 1 | 2019 | 1710 | 0.030 |
Why?
| | Clinical Enzyme Tests | 1 | 2013 | 11 | 0.030 |
Why?
| | Students | 1 | 2019 | 622 | 0.030 |
Why?
| | Salicylates | 1 | 2013 | 28 | 0.030 |
Why?
| | Respiratory Tract Infections | 1 | 2017 | 390 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1509 | 0.020 |
Why?
| | Blood Chemical Analysis | 1 | 2013 | 99 | 0.020 |
Why?
| | Time Management | 1 | 2012 | 20 | 0.020 |
Why?
| | Injury Severity Score | 1 | 2014 | 522 | 0.020 |
Why?
| | Recovery of Function | 1 | 2016 | 653 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2013 | 499 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1639 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 1023 | 0.020 |
Why?
| | Acetaminophen | 1 | 2013 | 268 | 0.020 |
Why?
| | Parents | 1 | 2018 | 1347 | 0.020 |
Why?
| | North America | 1 | 2010 | 313 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2010 | 565 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2016 | 2844 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2012 | 660 | 0.020 |
Why?
| | Young Adult | 2 | 2017 | 13209 | 0.020 |
Why?
| | Seizures, Febrile | 1 | 2006 | 21 | 0.020 |
Why?
| | Potassium Acetate | 1 | 2005 | 2 | 0.020 |
Why?
| | Infusions, Parenteral | 1 | 2005 | 40 | 0.010 |
Why?
| | Respiration Disorders | 1 | 2004 | 77 | 0.010 |
Why?
| | Middle Aged | 2 | 2019 | 33479 | 0.010 |
Why?
| | Respiratory Tract Diseases | 1 | 2005 | 184 | 0.010 |
Why?
| | Analgesics | 1 | 2005 | 206 | 0.010 |
Why?
| | Linear Models | 1 | 2005 | 849 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2005 | 2111 | 0.010 |
Why?
|
|
Bajaj's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|